Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling

Shobha Bhaskar1, V Shalini, A Helen

  • 1Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.

Immunobiology
|September 11, 2010
PubMed

Insights

Quercetin, a flavonoid, reduces inflammation by inhibiting Toll-like receptors (TLRs) and NF-κB signaling in response to oxidized LDL. This flavonoid modulates inflammatory pathways, offering a protective effect against cellular damage.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Toll-like receptors (TLRs) are crucial for innate and adaptive immunity, recognizing pathogens and initiating host defense.
  • TLRs activate signaling pathways, notably NF-κB, leading to cytokine production and adaptive immune responses.
  • Oxidized LDL (ox-LDL) is implicated in inflammatory processes, particularly in cardiovascular diseases.

Purpose of the Study:

  • To investigate the role of TLR2 and TLR4 in oxidized LDL-induced inflammation in human peripheral blood mononuclear cells (PBMCs).
  • To evaluate the effect of the flavonoid quercetin on the TLR-NF-κB signaling pathway in this model.
  • To assess quercetin's potential protective effects against ox-LDL-induced inflammation.

Main Methods:

  • Human PBMCs were treated with oxidized LDL (ox-LDL) and/or quercetin.
  • TLR2 and TLR4 expression levels were measured.
  • NF-κB p65 nuclear translocation was assessed.
  • Cytokine IL-6 production and inflammatory enzyme activity (5-LOX, COX) were quantified.
  • mRNA expression of iNOS and COX-2 was analyzed.

Main Results:

  • Ox-LDL significantly upregulated TLR2 and TLR4 expression and activated NF-κB signaling in PBMCs.
  • Quercetin treatment downregulated TLR2 and TLR4 expression and inhibited NF-κB p65 nuclear translocation.
  • Quercetin decreased IL-6 production, inflammatory enzyme activity, and mRNA expression of COX-2 and iNOS.
  • Quercetin demonstrated a protective effect against ox-LDL-induced inflammation.

Conclusions:

  • Quercetin modulates the TLR-NF-κB signaling pathway, reducing ox-LDL-induced inflammation in human PBMCs.
  • Quercetin inhibits TLR2 and TLR4 expression and downstream inflammatory mediators.
  • These findings highlight quercetin's potential therapeutic role in inflammatory conditions associated with oxidized LDL.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammation01:38

Inflammation

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...